Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIMBOW added to usual treatment for severe COPD exacerbation
2021-001429-34Phase 3Active
- Sponsor
- Hospital Universitari MútuaTerrassa
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium, formoterol, glycopyrronium and beclomethasone dipropionate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Hospital Universitari MútuaTerrassa. Started Oct 2021; status: active.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrroniumformoterolglycopyrroniumbeclomethasone dipropionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2021-001429-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001429-34.